CoChat
Sign Up
Cited by 2,432Respiratory Support and MechanismsIntensive Care Unit Cognitive DisordersAnesthesia and Sedative Agents

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome

Open access
Papazian, Laurent, Forel, Jean-Marie, Gacouin, Arnaud, Penot-Ragon, Christine, Perrin, Gilles, Loundou, Anderson, Jaber, Samir, Arnal, Jean-Michel, Perez, Didier, Seghboyan, Jean-Marie, Constantin, Jean-Michel, Courant, Pierre, Lefrant, Jean-Yves, Guérin, Claude, Prat, Gwenaël, Morange, Sophie, Roch, Antoine·2010·New England Journal of Medicine
DOI 10.1056/nejmoa1005372
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: In patients undergoing mechanical ventilation for the acute respiratory distress syndrome (ARDS), neuromuscular blocking agents may improve oxygenation and decrease ventilator-induced lung injury but may also cause muscle weakness. We evaluated clinical outcomes after 2 days of therapy with neuromuscular blocking agents in patients with early, severe ARDS. METHODS: In this multicenter, double-blind trial, 340 patients presenting to the intensive care unit (ICU) with an onset of severe ARDS within the previous 48 hours were randomly assigned to receive, for 48 hours, either cisatracurium besylate (178 patients) or placebo (162 patients). Severe ARDS was defined as a ratio of the partial pressure of arterial oxygen (PaO2) to the fraction of inspired oxygen (FIO2) of less than 150, with a positive end-expiratory pressure of 5 cm or more of water and a tidal volume of 6 to 8 ml per kilogram of predicted body weight. The primary outcome was the proportion of patients who died either before hospital discharge or within 90 days after study enrollment (i.e., the 90-day in-hospital mortality rate), adjusted for predefined covariates and baseline differences between groups with the use of a Cox model. RESULTS: The hazard ratio for death at 90 days in the cisatracurium group, as compared with the placebo group, was 0.68 (95% confidence interval [CI], 0.48 to 0.98; P=0.04), after adjustment for both the baseline PaO2:FIO2 and plateau pressure and the Simplified Acute Physiology II score. The crude 90-day mortality was 31.6% (95% CI, 25.2 to 38.8) in the cisatracurium group and 40.7% (95% CI, 33.5 to 48.4) in the placebo group (P=0.08). Mortality at 28 days was 23.7% (95% CI, 18.1 to 30.5) with cisatracurium and 33.3% (95% CI, 26.5 to 40.9) with placebo (P=0.05). The rate of ICU-acquired paresis did not differ significantly between the two groups. CONCLUSIONS: In patients with severe ARDS, early administration of a neuromuscular blocking agent improved the adjusted 90-day survival and increased the time off the ventilator without increasing muscle weakness. (Funded by Assistance Publique-Hôpitaux de Marseille and the Programme Hospitalier de Recherche Clinique Régional 2004-26 of the French Ministry of Health; ClinicalTrials.gov number, NCT00299650.)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1005372

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 29 references

Research works printed but not linked: 1

  1. 10.1001/jama.266.20.2870 · DOI · Paper page

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Papazian, L., Forel, J.-M., Gacouin, A., Penot-Ragon, C., Perrin, G., Loundou, A., Jaber, S., Arnal, J.-M., Perez, D., Seghboyan, J.-M., Constantin, J.-M., Courant, P., Lefrant, J.-Y., Guérin, C., Prat, G., Morange, S., & Roch, A.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Université de la Méditerranée Aix-Marseille II (FR)
  • Hôpital Pontchaillou (FR)
  • Hôpital Sainte-Marguerite (FR)
  • Assistance Publique Hôpitaux de Marseille (FR)
  • Hôpital Saint Eloi (FR)
  • Centre Hospitalier Universitaire de Besançon (FR)
  • CHU Ambroise Paré (BE)
  • Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
  • Centre Hospitalier Universitaire de Nîmes (FR)
  • Hôpital de la Croix-Rousse (FR)
  • Inserm (FR)
ORCID
Venue
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Published
2010-09-16
Volume
363
Issue
12
Pages
1107-1116
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
DOI
10.1056/nejmoa1005372
OpenAlex
W2115186092
Cited by
2,432
References
29
Citations by year
2026: 86 · 2025: 114 · 2024: 111 · 2023: 130 · 2022: 166 · 2021: 181 · 2020: 268 · 2019: 185 · 2018: 186 · 2017: 190 · 2016: 201 · 2015: 134 · 2014: 151 · 2013: 131 · 2012: 107
FWCI
85.76
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
Keywords
cisatracurium, acute respiratory distress syndrome, mechanical ventilation, 90-day mortality, ventilator-induced lung injury, muscle weakness, oxygenation, intensive care unit patients, mortality risk factors, PaO2/FiO2 ratio, plateau pressure
MeSH terms
Atracurium, Combined Modality Therapy, Double-Blind Method, Humans, Infusions, Intravenous, Middle Aged, Multiple Organ Failure, Neuromuscular Blocking Agents, Pneumothorax, Respiration, Artificial, Respiratory Distress Syndrome, Ventilator Weaning, Survival Rate, Proportional Hazards Models, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review